Stockreport

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference [Yahoo! Finance]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transform [Read more]